MASSDEVICE ON CALL — British medical regulatory Kent Woods warned against reactionary reforms to the European device review process amid growing clamor for overhaul in light of the public health crisis surrounding substandard breast implants.
"The question that arises is whether the broad principle of how we do it in Europe is right or not?" Woods told a press briefing in London. "Are we looking for incremental improvements to a system that is in place, or are we looking for root and branch change?"
The call for a fundamental overhaul to the European system has grown louder in recent months as the European Commission and EU med-tech lobby Eucomed called for a revised framework for medical device review.
Late last year, news broke that France was considering a recall of 30,000 sets of breast implants supplied by Poly Implant Prothese over concerns that they might contain a non-authorized silicone gel known for high rupture rates.
Woods said that the breast implant issue is rare and that no medical device review system can perfectly protect against intentional fraud, Reuters reported.
White House saves $4.1 billion in stamping out Medicare fraud in 2011
The Obama administration saved $4.1 billion in 2011 through efforts to prevent fraud and abuse to the federal Medicare program, Healthwatch reported.
Bear blood product vying for hole left by Medtronic bone protein scandal
Aursos Inc. is looking to fill the hole left behind by Medtronic’s Infuse bone growth protein, raising funds and aiming to begin human trials in 2014, MedCity News reported.
GOP Sens push for deeper cuts to Medicare
Sens. Richard Burr (R-N.C.) and Tom Coburn (R-Okla.) called for major cuts in Medicare aimed at saving between $300 billion and $1 trillion over 10 years, The Hill reported.
Prosthetic feet: fewer procedures, higher prices
Medicare spending on artificial feet has climbed 60% in recent years while procedure volume has dropped hard, the Chicago Tribune reported.